Liu F, Chen D, Liao Y, Diao L, Liu Y, Wu M, Xue X, You C, Kang Y
Neurological Intensive Care Unit, West China Hospital, Sichuan University, Chengdu, China.
J Int Med Res. 2012;40(6):2321-6. doi: 10.1177/030006051204000630.
To investigate the effect of the Intrafix(®) SafeSet infusion apparatus on the incidence of phlebitis in patients being intravenously infused in a neurological intensive care unit (ICU).
Patients aged > 12 years, with no history of diabetes mellitus and no existing phlebitis, requiring a daily peripheral intravenous infusion of ≥ 8 h with the total period lasting ≥ 3 days, were enrolled. Infusions were performed using the Intrafix(®) SafeSet or normal infusion apparatus. Incidence of phlebitis (scored according to the Infusion Nursing Standards of Practice of the American Infusion Nurses Society) was analysed.
Patients (n = 1545) were allocated to Intrafix(®) SafeSet (n = 709) or normal infusion (n = 836) groups, matched for age, gender and preliminary diagnosis. Incidence of phlebitis was significantly higher using normal infusion apparatus compared with the Intrafix(®) SafeSet (23.4% versus 17.9%, respectively).
Intrafix(®) SafeSet infusion apparatus significantly reduced the incidence of phlebitis in patients in the neurological ICU, compared with normal infusion apparatus, and may be suitable for use in routine clinical practice.
探讨Intrafix(®) SafeSet输液装置对神经重症监护病房（ICU）静脉输液患者静脉炎发生率的影响。
纳入年龄大于12岁、无糖尿病病史且无现有静脉炎、每日外周静脉输液≥8小时且总疗程≥3天的患者。使用Intrafix(®) SafeSet或普通输液装置进行输液。分析静脉炎的发生率（根据美国输液护理学会的《输液护理实践标准》评分）。
患者（n = 1545）被分配到Intrafix(®) SafeSet组（n = 709）或普通输液组（n = 836），两组在年龄、性别和初步诊断方面相匹配。与Intrafix(®) SafeSet相比，使用普通输液装置时静脉炎的发生率显著更高（分别为23.4%和17.9%）。
与普通输液装置相比，Intrafix(®) SafeSet输液装置显著降低了神经ICU患者静脉炎的发生率，可能适用于常规临床实践。
